Kansas · 2025-2026 Regular Session · Bill
HB 2218: Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 2218 is a bill introduced in the Kansas House on February 3, 2025. According to its official title, it concerns: Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act. Primary sponsor: Committee on Health and Human Services. Most recent recorded action (February 19, 2026): Stricken from Calendar by Rule 1507.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Committee on Health and Human Services | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Stricken from Calendar by Rule 1507
- Committee of the Whole - Passed over and retain a place on the calendar
- Committee Report recommending bill be passed as amended by House Committee on Health and Human Services
- Introduced
- Referred to House Committee on Health and Human Services